IHC results demonstrated that in 14.4% (18 out of 96) of PCa samples, more than 10% of tumor cells showed a positive PD-L1 IHC signal, which is consistent with previous reports [25]. The gene discussed is CD274; the disease is posterior cortical atrophy.